These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3725023)

  • 1. [Control of platelet antiaggregation therapy using an electronic aggregometer on whole blood].
    Arpaia MR; Leonardo G; del Guercio R
    Minerva Cardioangiol; 1986 Apr; 34(4):195-8. PubMed ID: 3725023
    [No Abstract]   [Full Text] [Related]  

  • 2. [Platelet release proteins in plasma in peripheral arterial obliterative disease during ticlopidine administration].
    Klingemann HG; Egbring R
    Dtsch Med Wochenschr; 1982 Sep; 107(37):1388-91. PubMed ID: 7117151
    [No Abstract]   [Full Text] [Related]  

  • 3. [The antiaggregation effect of ticlopidine on blood platelets preliminary results and prospectives for studies in various diseases].
    Andriani A; Chiappetta MG; Fabiani M; Mosiello G; Beni A
    Clin Ter; 1983 Feb; 104(3):219-22. PubMed ID: 6345050
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of platelet aggregation in patients treated with ticlopidine].
    Sbalzarini G; Carniti E; Fiorini L; Iezzi BG
    Clin Ter; 1984 Nov; 111(3):247-50. PubMed ID: 6240365
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic effect of ticlopidine for ischemic leg ulcers.
    Katsumura T
    Agents Actions Suppl; 1984; 15():167-72. PubMed ID: 6385645
    [No Abstract]   [Full Text] [Related]  

  • 6. Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease.
    Wong S; Morel-Kopp MC; Chen Q; Appleberg M; Ward CM; Lewis DR
    Thromb Haemost; 2006 Jun; 95(6):1042-3. PubMed ID: 16732389
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic effect of ticlopidine, a new inhibitor of platelet aggregation, on chronic arterial occlusive diseases, a double-blind study versus placebo.
    Katsumura T; Mishima Y; Kamiya K; Sakaguchi S; Tanabe T; Sakuma A
    Angiology; 1982 Jun; 33(6):357-67. PubMed ID: 7046521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of ticlopidine on platelet functions in acute myocardial infarction. A double blind controlled trial.
    Knudsen JB; Kjøller E; Skagen K; Gormsen J
    Thromb Haemost; 1985 Jun; 53(3):332-6. PubMed ID: 3901391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of ticlopidine on the natural course of retinal vein occlusion.
    Houtsmuller AJ; Vermeulen JA; Klompe M; Zahn KJ; Henkes HE; Baarsma GS; Tijssen J
    Agents Actions Suppl; 1984; 15():219-29. PubMed ID: 6385648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effects of ticlopidine on platelet aggregation: study on 13 atherosclerotic patients].
    Lenci R; Galante A; Borzi M; Ariganello M; Sommariva L; Filice A; Cannata D
    Clin Ter; 1983 Feb; 104(3):205-9. PubMed ID: 6861457
    [No Abstract]   [Full Text] [Related]  

  • 11. A platelet aggregation inhibitor--ticlopidine--in diabetic nephropathy: a randomized double blind study.
    Nyberg G; Larsson O; Westberg NG; Aurell M; Jagenburg R; Blohmé G
    Clin Nephrol; 1984 Mar; 21(3):184-7. PubMed ID: 6705280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-platelet aggregation action and paradoxical effects of acetylsalicylic acid].
    Mocchi N; Sbalzarini G; Cantaluppi P
    Clin Ter; 1985 Jul; 114(1):37-41. PubMed ID: 4042578
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of ticlopidine of platelet function in men with stable angina pectoris.
    Berglund U; von Schenck H; Wallentin L
    Thromb Haemost; 1985 Dec; 54(4):808-12. PubMed ID: 3911481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview: clinical experiences with ticlopidine.
    Day HJ
    Agents Actions Suppl; 1984; 15():297-309. PubMed ID: 6385654
    [No Abstract]   [Full Text] [Related]  

  • 15. The light-scattering whole blood aggregometer: a novel device for assessment of platelet aggregation in undiluted blood.
    Zheng Y; Solen KA; Mohammad SF
    Arch Pathol Lab Med; 1998 Oct; 122(10):880-6. PubMed ID: 9786348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV
    Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on the relationship of plasma fibrinogen, platelet aggregation rate and peripheral arterial occlusive disease].
    Wang J; Li XY; He Y; Ni B
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Jan; 26(1):1-4. PubMed ID: 15921581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute coronary syndrome, stroke, arterial occlusive disease. Bring the patients out of the danger zone!].
    Füessl HS
    MMW Fortschr Med; 2004; 146 Suppl 1():3. PubMed ID: 15493407
    [No Abstract]   [Full Text] [Related]  

  • 19. Response to aspirin and clopidogrel monitored with different platelet function methods.
    Mani H; Linnemann B; Luxembourg B; Kirchmayr K; Lindhoff-Last E
    Platelets; 2006 Aug; 17(5):303-10. PubMed ID: 16928602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of ticlopidine on peripheral obliterating arteriopathy].
    Stiegler H; Hess H; Mietaschk A; Trampisch HJ; Ingrisch H
    Dtsch Med Wochenschr; 1984 Aug; 109(33):1240-3. PubMed ID: 6381015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.